Device Spine/Spine Surgery

Ellipse/Addition C

Payments companies reported to CMS as associated with Ellipse/Addition C. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$10Kassociated payments (2023-2025)
26clinicians with associated payments
1company reporting

By year

2023 $8,725
2024 $1,671

Payments reported as associated with Ellipse/Addition C, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $5,205
Orthopaedic Surgery of The Spine $4,839
Physical Medicine & Rehabilitation $258
Physician Assistant $27.48
Orthopaedic Surgery $26.42
Adult Reconstructive Orthopaedic Surgery $26.42

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ellipse/Addition C

These are the largest totals companies reported as associated with Ellipse/Addition C. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Arnold Vardiman San Antonio, TX Neurological Surgery $3,285.98
Mark Eskenazi Delray Beach, FL Orthopaedic Surgery of The Spine $2,110.59
Scott Rushton Wynnewood, PA Orthopaedic Surgery of The Spine $2,007.63
John Steck Marrero, LA Neurological Surgery $1,447.18
Ted Brindle Roseville, CA Neurological Surgery $272.33
Gurtej Singh Catonsville, MD Physical Medicine & Rehabilitation $128.87
Chukwuemeka Nwodim Hanover, MD Orthopaedic Surgery of The Spine $128.87
Addisu Mesfin Rochester, NY Orthopaedic Surgery of The Spine $128.86
Sanjog Mathur Columbia, MD Orthopaedic Surgery of The Spine $128.86
Jesse Lou Germantown, MD Physical Medicine & Rehabilitation $128.86

Prescribed Ellipse/Addition C?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.